Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simpler nerve block keep blood sugar steady after lung surgery?

NCT ID NCT07754916

Not yet recruiting Symptom relief Sponsor: Xiangya Hospital of Central South University Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This trial tests whether one type of nerve block (intercostal) is as good as another (paravertebral) for controlling pain and keeping blood sugar levels stable in the first two days after minimally invasive lung surgery. The study involves 64 adults aged 18-70 who are scheduled for video-assisted lung resection. Participants will receive one of the two blocks with a long-acting local anesthetic, and researchers will measure blood sugar variability, pain scores, and recovery quality to see if the simpler block works just as well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomal bupivacaine
What this could lead to
If successful, this could show that a simpler nerve block provides equal pain control and blood sugar stability after lung surgery, potentially improving recovery and reducing complications.
What could go wrong
This is a small, early-stage trial, and the results may not apply to all patients. The non-inferiority design means it can only show the simpler block is not worse, not that it is better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLYCEMIC VARIABILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLYCEMIC VARIABILITY THORACIC SURGERY

Contacts and locations

Locations

  • Department of Anesthesiology, Xiangya Hospital, Central South University

    Changsha, Hunan, 410000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.